VYNT

Vyant Bio, Inc. Common Stock
VYNT

Overview Fund Activity
Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

26 hedge funds and large institutions have $7.88M invested in Vyant Bio, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.

Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
5
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$964K
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$33K
3
SIM
3
Spark Investment Management
New York
$19K
4
CPA
4
Court Place Advisors
Maryland
$17K
5
SEI Investments
5
SEI Investments
Pennsylvania
$8K

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$100K
2
TSS
2
Two Sigma Securities
New York
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$794K
4
PCM
4
Perkins Capital Management
Minnesota
$1.59M
5
Squarepoint
5
Squarepoint
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TDC
26
Thompson Davis & Co
Virginia
$1K – – –
TSS
27
Two Sigma Securities
New York
– -$125K -451 Closed
Squarepoint
28
Squarepoint
New York
– -$36K -130 Closed
Macquarie Group
29
Macquarie Group
Australia
– -$7K -26 Closed
1
2